Testicular Cancer

Testicular Cancer, explained simply

Everything a patient or caregiver wants to understand: what testicular cancer is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is testicular cancer?

Testicular cancer begins in a testicle, the male reproductive gland that makes sperm and testosterone. It is the most common cancer in young men, typically between the late teens and late thirties, and it is also one of medicine's great success stories — it is highly curable even when it has spread, thanks to very effective surgery, chemotherapy, and radiation. Most testicular cancers start in the germ cells, which make sperm, and they fall into two main families: seminomas and non-seminomas, which behave and are treated somewhat differently. A blood test for tumor markers helps diagnose and follow the disease, and the first step is almost always surgery to remove the affected testicle, which both treats the cancer and confirms the diagnosis. Because cure rates are so high, a major focus of modern care is achieving cure while minimizing long-term side effects.

In one line: Testicular cancer is among the most curable of all cancers, even when it has spread; for one common type, low-dose radiation is a proven, well-tolerated option after surgery.

The main types

Doctors group testicular cancer by where it starts and how it behaves:

TypeWhat it means, simply
SeminomaA germ-cell cancer that tends to grow more slowly and is especially sensitive to both radiation and chemotherapy.
Non-seminomaA group that includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma; often grows faster and is usually treated with surgery and chemotherapy rather than radiation.
Mixed germ-cell tumorA tumor containing both seminoma and non-seminoma elements, treated according to the non-seminoma components.
Stromal tumors (rare)Uncommon tumors from the hormone-producing or supportive cells of the testicle, usually treated mainly with surgery.

Staging, in plain terms

Testicular cancer staging is unusual because it adds a fourth letter — S — for blood tumor markers (proteins like AFP, beta-hCG, and LDH) alongside the usual tumor (T), node (N), and spread (M) categories. These markers help judge how much cancer is present and how it responds to treatment. In broad terms, doctors sort the disease into three stages based on whether it's confined to the testicle, has reached lymph nodes in the abdomen, or has spread further.

AJCC TNM plus serum tumor markers (TNMS)What it generally means
Stage ICancer is confined to the testicle and removed by surgery; cure rates approach 100%, with options of close monitoring or a single preventive treatment.
Stage IISpread to lymph nodes in the abdomen; treated with radiation (for seminoma) or chemotherapy, often still with excellent cure rates.
Stage IIISpread beyond the abdominal nodes to distant sites such as the lungs; chemotherapy is the mainstay and cures the large majority even at this stage.
Marker status (S)Blood tumor-marker levels are folded into staging and risk grouping, helping guide how intensive treatment should be.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Testicular Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Surgery (orchiectomy)

Removing the affected testicle is the first treatment for nearly everyone; it cures most early cancers and provides the exact diagnosis to guide any further treatment.

Surveillance

For many stage I cancers, close monitoring with exams, blood markers, and scans avoids extra treatment while catching any return early — when it remains highly curable.

Chemotherapy

Highly effective drug combinations (based on cisplatin) cure most testicular cancers that have spread and are used for both seminoma and non-seminoma in higher stages.

Radiation therapy

For seminoma, low-dose radiation to the abdominal lymph nodes is a well-established, well-tolerated option — used to treat early node spread or, less often now, to prevent recurrence.

How radiation treatment works

Radiation uses focused high-energy x-rays to damage the DNA of cancer cells so they can no longer divide. Seminoma — one of the two main types of testicular cancer — happens to be exceptionally sensitive to radiation, which is why even relatively low doses are highly effective against it. After the testicle is removed, seminoma tends to spread first to the lymph nodes at the back of the abdomen, so radiation can be aimed precisely at those nodes to clear or prevent disease there. Modern treatment uses lower doses and tightly shaped fields compared with decades past, sparing the intestines, kidneys, and other organs and keeping side effects mild — usually temporary fatigue or mild nausea. Treatments are painless and brief, given over a small number of sessions. Because surveillance and chemotherapy are also excellent options, your team will weigh radiation's benefits against alternatives to choose the approach that cures with the least long-term burden.

The main ways radiation is delivered for testicular cancer:

Radiation to abdominal lymph nodes

A modest, carefully shaped dose is directed at the lymph nodes along the back of the abdomen where seminoma tends to travel first, clearing or preventing disease there while sparing surrounding organs.

Low-dose preventive radiation

For some stage I seminomas, a short, low-dose course to the nearby lymph node area lowers the chance of recurrence, though active surveillance is now often preferred to avoid any treatment.

Targeted, image-guided delivery

Modern planning shapes the radiation field precisely and uses lower doses than in the past, reducing exposure to the bowel and other tissues and minimizing long-term effects.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Less treatment, same cure: Trials showed that lower radiation doses and smaller treatment fields cure early seminoma just as well as older, more intensive approaches, reducing side effects.[1]

MRC TE10/TE18/TE19 trials

Surveillance for stage I: Active monitoring after surgery spares most men with stage I disease any further treatment, reserving radiation or chemotherapy for the few who relapse — with cure rates still near 100%.[2]

Large stage I surveillance cohorts

Curing advanced disease: Cisplatin-based chemotherapy cures the majority of men even when testicular cancer has spread widely, making it one of the most curable solid cancers.[3]

Landmark germ-cell chemotherapy trials

Common questions

How curable is testicular cancer? Extremely. Caught early it is cured in nearly all cases, and even when it has spread to other organs, modern chemotherapy cures the large majority. Few cancers have such high cure rates, which is why the focus is on curing while keeping long-term side effects as low as possible.

Will radiation affect my fertility? Radiation is aimed at lymph nodes, not the remaining testicle, and shielding is used to protect it, but some scatter exposure is possible. Because cancer treatment can affect fertility, men are routinely offered sperm banking before treatment. Discuss fertility preservation with your team early.

Why might I get radiation instead of chemotherapy? Radiation is specifically effective for seminoma and is a well-established option for treating or preventing spread to the abdominal lymph nodes. Whether radiation, surveillance, or chemotherapy is best depends on your cancer's type and stage — your team will tailor the choice to give you the best cure with the fewest side effects.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. MRC TE10/TE18/TE19 trials (no indexed identifier — see your care team)
  2. Large stage I surveillance cohorts (no indexed identifier — see your care team)
  3. Landmark germ-cell chemotherapy trials (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides